filmov
tv
Biomarkers in ultra low-risk myeloma

Показать описание
Meral Beksac, MD, Ankara University, Ankara, Turkey, evaluates biomarkers of response in ultra low-risk multiple myeloma and the development of a genomic score that can be used for prognosis and treatment management. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).